Synergistic Anti-cancer Activity of MH-30 in a Murine Melanoma Model Treated With Cisplatin and its Alleviated Effects Against Cisplatin-induced Toxicity in Mice

Conclusion: Combination of MH-30 with cisplatin may be a beneficial anticancer treatment with reduced adverse effects.

Source: In Vivo - June 29, 2020 Category: Research Authors: PARK, H.-R., JO, S.-K., CHO, H.-H., JUNG, U. Tags: Experimental Studies Source Type: research